Multivariate Analyses of Mometasone Furoate versus Fixed Dose Combination of Salmeterol and Fluticasone Propionate in Mild Persistent Asthma Using an Administrative Claims Database

被引：0
|
作者：
McLaughlin, J. [1 ]
Navaratnam, P. [1 ]
Urdaneta, E. [2 ]
Friedman, H. S. [3 ]
机构：
[1] Informagenics LLC, Worthington, OH 07033 USA
[2] Schering Plough Corp, Kenilworth, NJ USA
[3] Analyt Solut LLC, New York, NY USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2009年 / 123卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
157
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 45 条
  • [31] Effects of Low Dose combination therapy, Fluticasone Propionate/Salmeterol Combination, 100/50 (FSC 100/50) on Exhaled Nitric Oxide (eNO) and Airway Hyperresponsiveness in Mild Persistent Asthma
    Pasha, M. A.
    Feustel, P. J.
    Smith, T.
    Patel, S.
    Sarathchandra, S.
    Malone, P.
    Evans, M.
    Jourd'heuil, F.
    Jourd'heuil, D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB159 - AB159
  • [32] Fixed-dose fluticasone propionate/salmeterol (FP/SAL) and budesonide/formoterol (BUD/FOR) comparative effectiveness in moderate-severe asthma: US database analysis
    Hamouda, Mohamed
    Hanania, Nicola
    Stanford, Richard
    Rendon, Adrian
    Gemicioglu, Bilun
    Fritscher, Leandro
    Boonsawat, Watchara
    Khan, Shireen Quli
    Stanford, Richard
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine
    Alyami, Mohammad H.
    Dahmash, Eman Zmaily
    Ali, Dalia Khalil
    Alyami, Hamad S.
    AbdulKarim, Hussien
    Alsudir, Samar A.
    PHARMACEUTICALS, 2022, 15 (03)
  • [34] One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
    Chapman, Kenneth
    van Zyl-Smit, Richard
    Maspero, Jorge
    Kerstjens, Huib A. M.
    Gon, Yasuhiro
    Hosoe, Motoi
    Tanase, Ana-Maria
    Pethe, Abhijit
    Shu, Xu
    D'Andrea, Peter
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [35] Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder
    Hagiwara, May
    Delea, Thomas E.
    Stanford, Richard H.
    JOURNAL OF ASTHMA, 2013, 50 (03) : 287 - 295
  • [36] Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
    Gessner, Christian
    Kornmann, Oliver
    Maspero, Jorge
    van Zyl-Smit, Richard
    Kruell, Matthias
    Salina, Anna
    Gupta, Pritam
    Bostel, Sebastien
    Fucile, Sebastian
    Conde, Lorena Garcia
    Pfister, Pascal
    RESPIRATORY MEDICINE, 2020, 170
  • [37] Long-Term Use of Fluticasone Propionate/Salmeterol Fixed-Dose Combination and Incidence of Nonvertebral Fractures Among Patients with COPD in the UK General Practice Research Database
    Miller, David P.
    Watkins, Stephanie E.
    Sampson, Tim
    Davis, Kourtney J.
    PHYSICIAN AND SPORTSMEDICINE, 2010, 38 (04): : 19 - 27
  • [38] Nitrogen Oxide Metabolites (Nitrite and Nitrate) in Exhaled Breath Condensates (EBC) from Patients with Mild Persistent Asthma, and Effects of Low Dose Combination Therapy Fluticasone Propionate/Salmeterol, 100/50 (FSC 100/50)
    Jourd'heuil, D.
    Feustel, P. J.
    Smith, T.
    Patel, S.
    Sarathchandra, S.
    Malone, P.
    Evans, M.
    Jourd'heuil, F.
    Pasha, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB8 - AB8
  • [39] The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice
    Doniec, Zbigniew
    Olszanecka-Glinianowicz, Magdalena
    Hantulik, Piotr
    Almgren-Rachtan, Agnieszka
    Chudek, Jerzy
    JOURNAL OF ASTHMA, 2023, 60 (04) : 754 - 760
  • [40] Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: Findings from a noninferiority trial
    Harnest, Ulf
    Price, David
    Howes, Tim
    Sussman, Gordon
    JOURNAL OF ASTHMA, 2008, 45 (03) : 215 - 220
12345